Literature DB >> 6175862

Home treatment in patients with antibody deficiency by slow subcutaneous infusion of gammaglobulin.

J J Roord, J W van der Meer, W Kuis, G E de Windt, B J Zegers, R van Furth, J W Stoop.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6175862

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

1.  Immune globulin subcutaneous (human), 20% liquid.

Authors: 
Journal:  P T       Date:  2010-08

2.  Immune globulin subcutaneous (human) vivaglobin: for the treatment of primary immunodeficiency diseases.

Authors: 
Journal:  P T       Date:  2009-06

3.  An immune globulin intravenous (human), 10% liquid privigen: for the treatment of primary immunodeficiency diseases.

Authors: 
Journal:  P T       Date:  2009-06

4.  Efficacy, safety, and pharmacokinetics of a 10% liquid immune globulin preparation (GAMMAGARD LIQUID, 10%) administered subcutaneously in subjects with primary immunodeficiency disease.

Authors:  Richard L Wasserman; Isaac Melamed; Lisa Kobrynski; Steven D Strausbaugh; Mark R Stein; Marlies Sharkhawy; Werner Engl; Heinz Leibl; Luba Sobolevsky; David Gelmont; Richard I Schiff; William J Grossman
Journal:  J Clin Immunol       Date:  2011-03-22       Impact factor: 8.317

5.  Pharmacokinetics of subcutaneous IgPro20 in patients with primary immunodeficiency.

Authors:  Richard L Wasserman; Isaac Melamed; Robert P Nelson; Alan P Knutsen; Mary Beth Fasano; Mark R Stein; Mikhail A Rojavin; Joseph A Church
Journal:  Clin Pharmacokinet       Date:  2011-06       Impact factor: 6.447

6.  Subcutaneous immunoglobulin-g replacement therapy with preparations currently available in the United States for intravenous or intramuscular use: reasons and regimens.

Authors:  Akhilesh Chouksey; Kimberly Duff; Nancy Wasserbauer; Melvin Berger
Journal:  Allergy Asthma Clin Immunol       Date:  2005-09-15       Impact factor: 3.406

7.  Immunoglobulin replacement treatment by rapid subcutaneous infusion.

Authors:  J Gaspar; B Gerritsen; A Jones
Journal:  Arch Dis Child       Date:  1998-07       Impact factor: 3.791

Review 8.  New Frontiers in Subcutaneous Immunoglobulin Treatment.

Authors:  Stephen Jolles; Mark R Stein; Hilary J Longhurst; Michael Borte; Bruce Ritchie; Matthias H Sturzenegger; Melvin Berger
Journal:  Biol Ther       Date:  2011-12-14

9.  II Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies.

Authors:  Ekaterini Simões Goudouris; Almerinda Maria do Rego Silva; Aluce Loureiro Ouricuri; Anete Sevciovic Grumach; Antonio Condino-Neto; Beatriz Tavares Costa-Carvalho; Carolina Cardoso Prando; Cristina Maria Kokron; Dewton de Moraes Vasconcelos; Fabíola Scancetti Tavares; Gesmar Rodrigues Silva Segundo; Irma Cecília Barreto; Mayra de Barros Dorna; Myrthes Anna Barros; Wilma Carvalho Neves Forte
Journal:  Einstein (Sao Paulo)       Date:  2017

10.  Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases.

Authors:  Lisa Kobrynski
Journal:  Biologics       Date:  2012-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.